Doctor Chiara Caselli

Association of serum MMP9 with adverse features of plaque progression in patients with chronic coronary syndrome (CCS).

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Lesion characteristics in coronary artery disease

Access

0

Differential association of high-sensitive cardiac Troponin T and Troponin I with coronary atherosclerotic burden, inducible ischemia and long-term prognosis in patients with chronic coronary syndrome

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Chronic ischaemia

Access

0

Association of eNOS Glu298Asp polymorphism with cardiometabolic risk and inducible myocardial ischemia in patients with stable coronary artery disease

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Chronic ischaemia

Access

0

Elevated triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina.

Event: ICNC-CT 2021

Topic: Plaque Imaging

Session: e-Posters

Access

0

Elevated TG/HDL-C ratio is an independent predictor of outcome and it is associated with CAD progression in patients with stable coronary artery disease.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Clinical

Session: Coronary Artery Disease (Chronic) ePosters

Access

0

Low PCSK9 plasma level is an independent predictor of coronary atherosclerotic burden in patients with stable coronary artery disease

Event: ESC CONGRESS 2019

Topic: Plaque Imaging

Session: Imaging the coronaries and plaques with Computed Tomography

Access

0

Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study

Event: ESC CONGRESS 2019

Topic: Plaque Imaging

Session: Imaging the coronaries and plaques with Computed Tomography

Access

0

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels are associated with the metabolic syndrome in patients with stable coronary artery disease

Event: ESC CONGRESS 2019

Topic: Lipids

Session: Lipids

Access

0

Expression profile of microRNAs in cardiac tissue from pediatric patients with heart failure (HF) supported by Ventricular Assist Device and their involvement in pathophysiological mechanisms of HF.

Event: ESC CONGRESS 2019

Topic: Ventricular Assist Devices

Session: Blockbusters from the Young - Cutting edge in heart failure

Access

0

Circulating microRNA profiling in serum of pediatric patients with heart failure submitted to VAD implant.

Event: ESC Congress 2018

Topic: Ventricular Assist Devices

Session: Advanced heart failure

Access

0

Doctor Chiara Caselli

Contributor content

Association of serum MMP9 with adverse features of plaque progression in patients with chronic coronary syndrome (CCS).

Differential association of high-sensitive cardiac Troponin T and Troponin I with coronary atherosclerotic burden, inducible ischemia and long-term prognosis in patients with chronic coronary syndrome

Association of eNOS Glu298Asp polymorphism with cardiometabolic risk and inducible myocardial ischemia in patients with stable coronary artery disease

Elevated triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina.

Elevated TG/HDL-C ratio is an independent predictor of outcome and it is associated with CAD progression in patients with stable coronary artery disease.

Low PCSK9 plasma level is an independent predictor of coronary atherosclerotic burden in patients with stable coronary artery disease

Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels are associated with the metabolic syndrome in patients with stable coronary artery disease

Expression profile of microRNAs in cardiac tissue from pediatric patients with heart failure (HF) supported by Ventricular Assist Device and their involvement in pathophysiological mechanisms of HF.

Circulating microRNA profiling in serum of pediatric patients with heart failure submitted to VAD implant.

ESC 365 is supported by